<DOC>
	<DOCNO>NCT00483470</DOCNO>
	<brief_summary>As per request Heath Authorities , present clinical study assess immunogenicity safety</brief_summary>
	<brief_title>Immunogenicity Safety Sanofi Pasteur 's AVAXIM 80U Pediatric Vaccine Followed Booster Dose</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion Criteria : Inclusion criterion check screen visit ( SC ) : 1 . Toddlers , child adolescent : SubGroup 1 : 12 month 3 year age day inclusion SubGroup 2 : 4 6 year age day inclusion SubGroup 3 : 7 9 year age day inclusion SubGroup 4 : 10 12 year age day inclusion SubGroup 5 : 13 15 year age day inclusion 2 . Screening informed consent form sign parent ( ) legal representative subject adolescent ( subgroup 5 ) Inclusion criterion check inclusion visit ( V01 ) : 1 . Toddlers , child adolescent : SubGroup 1 : 12 month 3 year age day inclusion SubGroup 2 : 4 6 year age day inclusion SubGroup 3 : 7 9 year age day inclusion SubGroup 4 : 10 12 year age day inclusion SubGroup 5 : 13 15 year age day inclusion 2 . Inclusion inform consent form sign parent ( ) legal representative subject adolescent ( subgroup 5 ) 3 . Able attend schedule visit comply trial procedure 4 . Subject antiHAV seronegative ( IgG ) accord screen result ( assay perform local kit ) 5 . Subject HBsAg seronegative ALT &lt; 40 IU/l accord screen result Exclusion Criteria : Exclusion criterion check inclusion visit ( V01 ) : 1 . Participation another clinical trial 4 week precede trial vaccination 2 . Planned participation another clinical trial present trial period 3 . Congenital acquire immunodeficiency , immunosuppressive therapy longterm systemic corticosteroid therapy 4 . Systemic hypersensitivity vaccine component history lifethreatening reaction trial vaccine vaccine contain substance 5 . Chronic illness stage could interfere trial conduct completion 6 . Blood bloodderived product receive past 3 month 7 . Any vaccination 4 week precede trial vaccination 8 . Any vaccination plan 4 week follow trial vaccination 9 . History hepatitis A infection ( confirm either clinically serologically ) 10 . Previous vaccination hepatitis A trial vaccine another hepatitis A vaccine 11 . Thrombocytopenia bleed disorder contraindicate intramuscular vaccination 12 . History /current seizures 13 . Clinical serological evidence systemic illness include Hepatitis C HIV 14 . Febrile ( axillary temperature ≥ 37.1°C ) acute illness</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Hepatitis A</keyword>
</DOC>